BCPT Publications

The following citations are of reports that have been published in the scientific literature concerning the Breast Cancer Prevention Trial (BCPT). The citations are listed in reverse chronological order.

2008 Publications

Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.

Authors: D Cella, SR Land, CH Chang, R Day, JP Costantino, N Wolmark, PA Ganz.
Journal: Breast Cancer Research and Treatment 109(3):515-26. (2008).

2007 Publications

Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.

Authors: D Cella, SR Land, CH Chang, R Day, JP Costantino, N Wolmark, PA Ganz.
Journal: Breast Cancer Research and Treatment 109(3):515-26. (2007).

2006 Publications

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Authors: N Abramson, JP Costantino, JE Garber, N Berliner, DL Wickerham, N Wolmark.
Journal: Journal of the National Cancer Institute 98(13):904-10. (2006).

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Authors: MS Beattie, JP Costantino, SR Cummings, DL Wickerham, VG Vogel, M Dowsett, EJ Folkerd, WC Willett, N Wolmark, SE Hankinson.
Journal: Journal of the National Cancer Institute 98(2):110-5. (2006).

2005 Publications

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.

Authors: E Chalas, JP Costantino, DL Wickerham, N Wolmark, GC Lewis, C Bergman, CD Runowicz.
Journal: American Journal of Obstetrics and Gynecology 192(4):1230-7; discussion 1237-9. (2005).

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Authors: B Fisher, JP Costantino, DL Wickerham, RS Cecchini, WM Cronin, A Robidoux, TB Bevers, MT Kavanah, JN Atkins, RG Margolese, CD Runowicz, JM James, LG Ford, N Wolmark.
Journal: Journal of the National Cancer Institute 97(22):1652-62. (2005).

2003 Publications

Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial.

Authors: M Cushman, JP Costantino, EG Bovill, DL Wickerham, L Buckley, JD Roberts, DN Krag.
Journal: British Journal of Haematology 120(1):109-16. (2003).

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

Authors: E Tan-Chiu, J Wang, JP Costantino, S Paik, C Butch, DL Wickerham, B Fisher, N Wolmark.
Journal: Journal of the National Cancer Institute 95(4):302-7. (2003).

2002 Publications

Factor V Leiden (FVL) and prothrombin G20210A (PTG) mutations and risk of thromboembolic events (TE) in NSABP P-1, the breast cancer prevention trial (BCPT). (Abstract not available online)

Authors: JE Garber, JP Costantino, DL Wickerham, N Berliner, N Wolmark.
Journal: Breast Cancer Research and Treatment 76(Suppl 1):A-413. (2002).

2001 Publications

Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study.

Authors: R Day, PA Ganz, JP Costantino.
Journal: Journal of the National Cancer Institute 93(21):1615-23. (2001).

Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.

Authors: R Day; National Surgical Adjuvant Breast and Bowel Project P-1 study (NSABP-1).
Journal: Annals of the New York Academy of Sciences 949:143-50. (2001).

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

Authors: MC King, S Wieand, K Hale, M Lee, T Walsh, K Owens, J Tait, L Ford, BK Dunn, J Costantino, L Wickerham, N Wolmark, B Fisher; National Surgical Adjuvant Breast and Bowel Project.
Journal: Journal of the American Medical Association 286(18):2251-6. (2001).

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

Authors: SE Reis, JP Costantino, DL Wickerham, E Tan-Chiu, J Wang, M Kavanah.
Journal: Journal of the National Cancer Institute 93(1):16-21. (2001).

The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).

Authors: N Wolmark, BK Dunn.
Journal: Annals of the New York Academy of Sciences 949:99-108. (2001).

1999 Publications

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors: JP Costantino, MH Gail, D Pee, S Anderson, CK Redmond, J Benichou, HS Wieand.
Journal: Journal of the National Cancer Institute 91(18):1541-8. (1999).

Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors: R Day, PA Ganz, JP Costantino, WM Cronin, DL Wickerham, B Fisher.
Journal: Journal of Clinical Oncology 17(9):2659-69. (1999).

1998 Publications

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors: B Fisher, JP Costantino, DL Wickerham, CK Redmond, M Kavanah, WM Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins, M Daly, S Wieand, E Tan-Chiu, L Ford, N Wolmark.
Journal: Journal of the National Cancer Institute 90(18):1371-88. (1998).

1995 Publications

Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.

Authors: PA Ganz, R Day, JE Ware Jr, C Redmond, B Fisher.
Journal: Journal of the National Cancer Institute 87(18):1372-82. (1995).

1993 Publications

The NSABP breast cancer prevention trial (BCPT): a progress report. (Abstract not available online)

Authors: CK Redmond, DL Wickerham, W Cronin, et al.
Journal: Proceedings of the American Society of Clinical Oncology 12:A-78, 69. (1993).